APA (7th ed.) Citation

D, H., X, J., N, Y., Y, W., Y, L., X, Y., . . . Y, S. (2025). Upadacitinib Versus Acitretin for the Resolution of Pustules in Palmoplantar Pustulosis During Acute Phase: A Single-Center, Open-Label Prospective Cohort Study. American journal of clinical dermatology, 26(5), 843. https://doi.org/10.1007/s40257-025-00971-7

Chicago Style (17th ed.) Citation

D, Huang, Jiang X, Yang N, Wang Y, Li Y, Yi X, Guo C, Gao Y, and Shi Y. "Upadacitinib Versus Acitretin for the Resolution of Pustules in Palmoplantar Pustulosis During Acute Phase: A Single-Center, Open-Label Prospective Cohort Study." American Journal of Clinical Dermatology 26, no. 5 (2025): 843. https://doi.org/10.1007/s40257-025-00971-7.

MLA (9th ed.) Citation

D, Huang, et al. "Upadacitinib Versus Acitretin for the Resolution of Pustules in Palmoplantar Pustulosis During Acute Phase: A Single-Center, Open-Label Prospective Cohort Study." American Journal of Clinical Dermatology, vol. 26, no. 5, 2025, p. 843, https://doi.org/10.1007/s40257-025-00971-7.